Status:
COMPLETED
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)
Lead Sponsor:
Auburn University
Conditions:
Alzheimer Disease
Cerebral Amyloid Angiopathy
Eligibility:
All Genders
55-75 years
Phase:
NA
Brief Summary
Until now there is no medical treatment and/or intervention that can slow, stop or reverse the underlying neurodegenerative of Alzheimer's disease (AD). The goal of this study is to demonstrate "Oleoc...
Eligibility Criteria
Inclusion
- Men and women, experiencing mild cognitive impairment with:
- Mini-Mental State Exam (MMSE) scores between 18-30 (based on education level
- memory complaint, have objective memory loss measured by education adjusted scores on Wechsler Memory Scale Logical Memory VI
- Clinical Dementia Rating (CDR) score 0.5.
Exclusion
- Subjects with contradictions for MRI include: the presence of metal or electronic devices such as metallic joint prostheses, artificial heart valves, an implantable heart defibrillator, a pacemaker, metal clips, cochlear implants, a bullet, shrapnel or any other type of metal fragment; breathing problems or disorders, claustrophobia, inner ear disorders, vertigo or dizziness, tattoos or permanent makeup that contains metal, and body piercing jewelry that cannot be removed.
- Subjects will be excluded if they are smokers
- Subjects who have have clinically important medical or neuropsychiatric comorbidity.
- Subjects who have renal problems or are allergic to the MRI contrast agent.
Key Trial Info
Start Date :
May 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03824197
Start Date
May 7 2019
End Date
December 31 2020
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Auburn University
Auburn, Alabama, United States, 36849